CD
Catherine T. Doherty (Executive Vice President) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $5.5M of DGX (22,105 sh across 7 lots, as filed), executed Nov 3. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$12.4M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $221.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $19.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
DGXRecent filings
DGXSALE
Quest Diagnostics Incorporated
View filing →
$154K899 sh × $170.99
Exec Feb 20 2025
Filed Feb 21 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $5.4M
33,103 sh across 2 lots
Exec Nov 27 2024
Filed Dec 2 2024 · 5:30 PM ET